Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.
Press releases published on July 7, 2025
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supported by a strong syndicate of early-stage …
Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework
RA'ANANA, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it is …
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Ripplecoin Mining cloud mining application is changing the way Ripple (XRP), Bitcoin (BTC), Solana holders make money
San Francisco, California, July 07, 2025 (GLOBE NEWSWIRE) -- Today's cryptocurrency market is volatile, and more and more XRP, BTC and Solana holders are looking for investment methods that do not rely on market fluctuations and can bring sustainable …
ParaZero Successfully Achieved 100% Effectiveness Against Fast-Incoming Drone Threats in Live Field Demonstration
The Live Field Demo with the Company’s DefendAir System was Showcased to Senior Israeli Defense Leadership Kfar Saba, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company …
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 ( …
Foresight: Eye-Net and Leading European Vehicle Manufacturer Successfully Advance Vehicle Safety with First-Phase Testing
The POC project aims to integrate Eye-Net’s technology into the safety systems of the vehicle manufacturer’s vehicles, creating a comprehensive ecosystem that connects the vehicle, vulnerable road users, and surrounding infrastructure for enhanced …
Medical Supplierz Expands Global Access to Leading Medical Manufacturers
KUWAIT, KUWAIT, July 7, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B procurement platform, has launched new initiatives to strengthen global connectivity between verified healthcare buyers and trusted medical manufacturers. The platform …
Vortex Energy Announces ANT Survey Sampling Plan for Robinsons River Salt Project
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce the finalized sampling plan for the Ambient Noise Tomography (ANT) geophysical survey …
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …
Medicines for Poland Announces: Without pharmaceutical factories Europe will lose any war
BRUSSELS, July 07, 2025 (GLOBE NEWSWIRE) -- The need to establish a fund under the EU budget to support the production of critical medicines in Europe is a conclusion drawn from an analysis of the impact of the war on the availability of medicines in …
HUB Cyber Security (Nasdaq: HUBC) Appoints Aviv Eyal to Lead AI-Native Digital Asset Infrastructure Division
TEL AVIV, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in zero-trust confidential computing, secured data fabric infrastructure and AI-native security orchestration, today …
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro …
Redevances OR annonce les livraisons préliminaires d’onces d’équivalent d’or pour le deuxième trimestre de 2025 et des produits trimestriels et une marge monétaire records
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Redevances OR Inc. (la « Société » ou « Redevances OR ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses produits et sa marge monétaire préliminaires pour le deuxième trimestre …
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new …
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development. Mr. Ghias joins BioCryst from …
Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West
MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2025 program at Boumadine in the Kingdom of Morocco. Today's …
Aya Or & Argent inc. publie des résultats d’exploration à haute teneur à Boumadine, augmente l’étendue de la zone Imariren à 1 km et identifie la zone Asirem, une nouvelle zone à haute teneur à l’ouest
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer les nouveaux résultats de forage d’exploration à haute teneur issus de son programme 2025 à Boumadine, dans le …
Lancaster Strengthens Gold Portfolio with Completion of Lake Cargelligo Acquisition
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”, the “Company”) is pleased to announce the completion of its acquisition of 100% of the Lake Cargelligo Gold Project, …